Central Line Associated Blood Stream Infections (CLABSI)

CLABSI is a primary laboratory confirmed bloodstream infection in a patient with a central line at the time of (or within 48-hours prior to) the onset of symptoms and the infection is not related to an infection from another site. These infections are usually serious infections typically causing a prolongation of hospital stay and increased cost and risk of mortality.
 

Central Line Associated Blood Stream Infection (CLABSI) Tool Kit  


Free CUSP Toolkit Can Help Clinicians Make Care Safer

AHRQ's Comprehensive Unit-based Safety Program (CUSP) toolkit includes training tools to make care safer by improving the foundation of how physicians, nurses, and other clinical team members work together. It combines a checklist of clinical best practices with an understanding of the science of safety, improved safety culture, and an increased focus on teamwork and communication. In a nationwide project to promote the use of CUSP, more than 1,000 ICUs reduced central line-associated bloodstream infections by 41 percent.

Click here...


What It Takes To Eliminate Blood Stream Infections - An AHRQ-Funded Joint Initiative

 
Central line-associated bloodstream infections kill 31,000 patients a year; nearly as many deaths as breast cancer.  Most of these infections are preventable and you are part of the cure. We have seen an ever-increasing number of hospitals reach and sustain a rate of zero central line-associated bloodstream infections (CLABSIs) for over a year. Each quarterly report of data shows that many clinical areas can eliminate CLABSIs.  You can too.  There is no single therapy that will wipe out these infections.  It will take the concerted efforts of many people and tasks to reach zero.


Read More>>


 

National Healthcare Safety Network Launches Hospital TAP Reports

The National Healthcare Safety Network now offers reports that can help hospitals target their infection prevention efforts, the Centers for Disease Control and Prevention announced today. The Targeted Assessment for Prevention reports allow authorized users to identify facilities within a group or units within a facility with more infections than predicted based on Standardized Infection Ratio targets for catheter-associated urinary tract infection, central line-associated bloodstream infection and Clostridium difficile. "AHA is pleased that CDC is making this tool available to hospitals that are looking to make further strides in reducing infections by being able to target areas that may provide the greatest opportunity for improvement," said John Combes, M.D., AHA senior vice president and chief medical officer.

Click here for more on the reports»